Clinical characteristics and early outcomes in patients with COVID-19 treated with tocilizumab at a United States academic center
Rimland, C. A.; Morgan, C. E.; Bell, G. J.; Kim, M. K.; Hedrick, T.; Marx, A.; Bramson, B.; Swygard, H.; Napravnik, S.; Schmitz, J. L.; Carson, S. S.; Fischer, W. A.; Eron, J. J.; Gay, C. L.; Parr, J. B.
Show abstract
We describe early outcomes in 11 COVID-19 patients treated with the IL-6 receptor inhibitor tocilizumab. While C-reactive protein decreased, neither clinical improvement nor reduced temperature or oxygen requirements was observed in most patients. Our findings contrast with prior reports and raise questions about tocilizumab use in severe COVID-19.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Hydroxychloroquine and Tocilizumab Therapy in COVID-19 Patients - An Observational Study 93%
- Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 Infection 92%
- Efficacy of Corticosteroids in Non-Intensive Care Unit Patients with COVID-19 Pneumonia from the New York Metropolitan region 92%
Similar papers in this journal
- Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia 92%
- Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial 91%
- The longest persistence of viable SARS-CoV-2 with recurrence of viremia and relapsing symptomatic COVID-19 in an immunocompromised patient – a case study 91%
Similar papers in this journal
- A retrospective study evaluating efficacy and safety of compassionate use of tocilizumab in 13 patients with severe-to-critically ill COVID-19: analysis of well-responding cases and rapidly-worsening cases after tocilizumab administration 95%
- First report of tocilizumab use in a cohort of Latin American patients hospitalized for severe COVID-19 pneumonia 93%
- Current Understanding of COVID-19 Clinical Course and Investigational Treatments 93%
Similar papers in this journal
- Early Short Course Corticosteroids in Hospitalized Patients with COVID-19 94%
- Compassionate Use of REGEN-COV ® in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders 93%
- A Multi-center, Prospective, Observational-cohort controlled study of Clinical Outcomes following COVID-19 Convalescent plasma therapy in hospitalized COVID-19 patients 91%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.